During the past decade, Pecsi Tudomanyegyetem, Klinikai Kozpont, conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 26 clinical trials were completed, i.e. on average, 60.5% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 21 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pecsi Tudomanyegyetem, Klinikai Kozpont," #1 sponsor was "Bayer" with 10 trials, followed by "Pfizer" with 10 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Amgen" with 4 trials sponsored and "Actelion" with 4 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pecsi Tudomanyegyetem, Klinikai Kozpont," #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Pecsi Tudomanyegyetem, Klinikai Kozpont," are "Ulcerative Colitis" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Depressive Disorder, Major" (2 trials), "Epilepsy, Partial Seizures" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Pecsi Tudomanyegyetem, Klinikai Kozpont," in a lesser frequency.

Most popular intervention types in "Pecsi Tudomanyegyetem, Klinikai Kozpont," are "Drug" (50 trials), "Other" (9 trials), "Biological" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "BAY2433334" (2 trials) and "BAY2433334 matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pecsi Tudomanyegyetem, Klinikai Kozpont," are 50 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pecsi Tudomanyegyetem, Klinikai Kozpont,". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Pecsi Tudomanyegyetem, Klinikai Kozpont,, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Pecsi Tudomanyegyetem, Klinikai Kozpont,, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".